Oxycodone

Generic Name
Oxycodone
Brand Names
Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
Drug Type
Small Molecule
Chemical Formula
C18H21NO4
CAS Number
76-42-6
Unique Ingredient Identifier
CD35PMG570
Background

Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...

Indication

Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.

Associated Conditions
Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
Associated Therapies
-

Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy

First Posted Date
2016-10-18
Last Posted Date
2016-10-18
Lead Sponsor
Hospital Civil de Guadalajara
Target Recruit Count
64
Registration Number
NCT02936934

Celecoxib After Tonsillectomy

First Posted Date
2016-10-14
Last Posted Date
2020-03-10
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
172
Registration Number
NCT02934191
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Cannabis Versus Oxycodone for Pain Relief

First Posted Date
2016-09-08
Last Posted Date
2024-02-22
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
33
Registration Number
NCT02892591
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Malaysian Population

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-04-05
Last Posted Date
2022-01-28
Lead Sponsor
University of Malaya
Target Recruit Count
33
Registration Number
NCT02728648
Locations
🇲🇾

Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

First Posted Date
2016-01-21
Last Posted Date
2018-11-19
Lead Sponsor
Mundipharma Korea Ltd
Target Recruit Count
66
Registration Number
NCT02660229
Locations
🇰🇷

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of

Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo

First Posted Date
2015-11-13
Last Posted Date
2021-11-16
Lead Sponsor
St. Olavs Hospital
Target Recruit Count
134
Registration Number
NCT02604446
Locations
🇳🇴

Anestesiavdelingen, St Olavs Hospital, Trondheim, Norway

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

First Posted Date
2015-11-10
Last Posted Date
2021-09-23
Lead Sponsor
Stanford University
Target Recruit Count
120
Registration Number
NCT02601027
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

© Copyright 2024. All Rights Reserved by MedPath